Nuclear Medicine: Page 18

Road to RSNA 2022: Molecular Imaging Preview

By Will Morton

This year's nuclear medicine and molecular imaging program at RSNA 2022 resounds with the impact of theranostics on the lives of patients with prostate cancer, with prostate-specific membrane antigen PET imaging taking center stage. Organizers even saw fit to title one scientific session "Prostate and Theranostics Potpourri."

November 21, 2022

NorthStar to build a new development and manufacturing services unit

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes plans to expand its business with a new radiopharmaceutical Contract Development and Manufacturing Organization services unit it will build on its Beloit, WI, campus.

November 14, 2022

Predicting outcomes post coronary artery surgery: SPECT or angio?

By Will Morton

SPECT myocardial perfusion imaging may be a better approach than coronary angiography for predicting survival of patients after coronary artery bypass, according to a study published November 9 in The Annals of Thoracic Surgery.

November 13, 2022

Nuclear reactor inspections impact Mo-99 supplies

By AuntMinnie.com staff writers

A shortage in global supplies of molybdenum-99 (Mo-99) and iodine-131 is expected due to a mechanical failure at Belgium's BR2 reactor in Mol, according to a report by Nuclear Medicine Europe.

October 31, 2022

QIBA announces inaugural fellowship recipients

By AuntMinnie.com staff writers

The RSNA's Quantitative Imaging Biomarkers Alliance (QIBA) and its partner, the Academy for Radiology & Biomedical Imaging Research, have announced recipients of the first Academy Council of Early Career Investigators in Imaging fellowship.

October 30, 2022

ViewRay touts results of MIRAGE trial

By AuntMinnie.com staff writers

ViewRay highlighted results from its phase III Magnetic Resonance Imaging-Guided Stereotactic Body Radiotherapy for Prostate Cancer (MIRAGE) trial at the recent American Society for Radiation Oncology annual meeting in San Antonio.

October 26, 2022

ITM-11 gets fast-track nod from FDA

By AuntMinnie.com staff writers

ITM Isotope Technologies Munich SE's ITM-11 was recently granted fast-track designation by the U.S. Food and Drug Administration (FDA).

October 26, 2022

DOE breaks ground on new isotope research facility

By AuntMinnie.com staff writers

The U.S. Department of Energy (DOE) broke ground October 24 on a new isotope research facility at Oak Ridge National Laboratory (ORNL) in Tennessee.

October 25, 2022

Spectrum highlights new SPECT/CT capability

By AuntMinnie.com staff writers

Spectrum Dynamics is highlighting a new nuclear medicine imaging capability: to image high-energy isotopes using solid-state detector technology in a 360˚ cadmium zinc telluride-based, wide-bore SPECT/CT configuration.

October 19, 2022

Shine secures Dutch approval for terbium isotope development grant

By AuntMinnie.com staff writers

Shine Technologies has secured approval from the Dutch government for a grant proposal to develop terbium isotopes for nuclear medicine imaging.

October 17, 2022

ITM to boost Lu-177 production

By AuntMinnie.com staff writers

ITM Isotope Technologies Munich completed work on a new production line for non-carrier-added lutetium-177 (Lu-177) at its manufacturing facility in Garching, Germany.

October 12, 2022

Nucleus RadioPharma forms to provide radiopharmaceuticals

By AuntMinnie.com staff writers

Venture capital firm Eclipse and the Mayo Clinic are creating and providing seed funding for a new company called Nucleus RadioPharma that aims to provide cancer patients access to therapeutic radiopharmaceuticals.

October 11, 2022

Previous Page

Page 18 of 440

Next Page